Horizon Space Acquisition II Seeks Shareholder Approval to Extend SPAC Deadline to February 2027

summarizeSummary

Horizon Space Acquisition II Corp. is seeking shareholder approval to amend its organizational documents, allowing it to extend the deadline for completing a business combination by up to 12 additional months, pushing the potential termination date to February 18, 2027.

check_boxKey Events

• Proposed Deadline Extension

  Shareholders will vote on amending the company's articles of association and trust agreement to extend the deadline for completing a business combination.

• New Termination Date

  If approved, the company can extend its operational period by up to twelve additional one-month increments, moving the final deadline from February 18, 2026 (or May 18, 2026, if fully extended) to February 18, 2027.

• Sponsor Funding for Extensions

  Each monthly extension will require the sponsor or its designee to deposit the lesser of $50,000 or $0.033 per remaining public share into the trust account.

• Existing Business Combination

  The company has a pending business combination agreement with SL Bio Ltd., with a shareholder meeting for approval scheduled for February 3, 2026.

auto_awesomeAnalysis

This preliminary proxy statement outlines critical proposals for Horizon Space Acquisition II Corp., a SPAC, to extend its operational timeline. The company faces a February 18, 2026 deadline to complete a business combination, with an existing merger agreement with SL Bio Ltd. already in place. The proposed amendments would allow for monthly extensions until February 2027, funded by the sponsor, to provide more time and flexibility. Failure to approve these extensions would likely lead to the company's liquidation. While the extension offers a lifeline to complete the proposed merger or an alternative, it also signals potential delays and continued uncertainty, which is common for SPACs nearing their termination dates. Shareholders have the option to redeem their shares at approximately $10.53, which is slightly below the current market price of $10.575.